200 36700 advanced:3.55891312765391 cancer:1.54401010711165 case:0.325148690291958 cohort:2.32203570971108 control:0.919855798038651 design:2.29943659920322 draw:1.80971327284465 eric:4.53974238066564 figure:1.80971327284465 follow:2.04646830498498 gonna:3.55891312765391 health:2.6957904563707 levels:1.07400647786591 lorelei:4.53974238066564 mucci:4.25206030821386 nested:2.93030446823154 professionals:6.88226018399506 prostate:3.84659520010569 remember:0.417998844255421 researchers:3.89895043043962 rimm:4.53974238066564 risk:0.614474148487469 selenium:3.84659520010569 started:0.748005541111992 study:2.07214292158254 talk:0.84683782344952 thought:1.92478260262944 undertook:4.53974238066564
36700 77130 reason:3.55891312765391 initially:3.0880202142233 investigators:1.68711095075232 study:1.94947521521981 men:2.38025813131226 men:2.38025813131226 free:1.44869992730732 questionnaire:2.27105883934727 year:0.675510039073838 started:1.66806275578162 50000:3.84659520010569 1986:4.08506565095307 source:4.25206030821386 cancer:3.84659520010569 invited:2.74798291143758 interesting:0.834333624600489 toenails:2.54731221597543 cancer:0.748005541111992 50000:0.59204083473787 biomarkers:0.859231176222216 study:1.92478260262944 thought:8.0578335137993 men:0.970126149671934
77130 120560 1987:3.24045939653538 beginning:1.51122028428865 biological:3.24045939653538 population:0.325148690291958 clipping:4.02891675689965 nested:0.919855798038651 control:4.9452074887738 end:0.802072762382268 factors:0.90215622093925 health:1.02323415249249 study:4.9452074887738 grow:3.15344801954575 happened:0.60791674794131 37000:1.34789522818535 levels:1.07400647786591 toenails:2.74798291143758 50000:1.36168855031769 nail:4.25206030821386 source:2.93030446823154 part:1.0844777777332 study:0.514390689930487 previous:0.867670044868081 man:3.44113009199753 reflect:1.49521994294221 follow:2.54731221597543 specimens:3.69244452027843 study:1.18408166947574 taking:0.859231176222216 toenail:8.0578335137993 year:0.485063074835967
120560 160850 back:0.489454245962768 larry:7.69319040021138 study:1.68711095075232 published:4.9452074887738 selenium:3.84659520010569 hypothesis:3.80672045060016 hypothesis:9.8904149775476 study:1.07400647786591 measure:1.66806275578162 toenails:0.793215308548206 trial:2.38025813131226 referred:1.17244655067916 study:1.38985942728439 stored:7.69319040021138 back:2.99929733971849 clark:1.18408166947574 hypothesis:8.0578335137993 randomized:1.54401010711165 collection:0.956223442209526
160850 197390 study:7.11782625530782 follow:1.28164584264415 basically:3.0880202142233 nested:0.975446070875874 case:1.8397115960773 study:4.9452074887738 ed:0.802072762382268 1996:1.02323415249249 37000:1.36168855031769 undertook:2.93030446823154 prostate:1.57791165878733 cases:1.78820706762369 1994:7.69319040021138 advanced:0.614474148487469 cancer:0.668541369757745 undertook:1.44869992730732 prostate:0.37566448042886 control:0.888061252106805 men:9.07948476133128
197390 236090 prostate:1.54401010711165 case:0.650297380583916 researchers:0.634408363388287 selected:1.8397115960773 risk:0.87618073453599 compare:2.41947884446554 specimen:0.778542264972074 health:1.02323415249249 37000:1.34789522818535 identified:1.83169217956343 1988:0.810040932031445 means:0.526366880977203 looked:2.72337710063538 control:5.86060893646308 number:0.153557735843091 men:3.44113009199753 developing:3.84659520010569 remember:0.417998844255421 toenail:1.94947521521981 find:0.634408363388287 risk:1.84342244546241 set:0.668541369757745 time:1.44869992730732 set:0.75132896085772 study:3.69244452027843 control:0.888061252106805 cancer:0.0700101655726489 follow:4.02891675689965
236090 263310 develop:3.55891312765391 cancer:3.0880202142233 follow:0.325148690291958 clark:3.84659520010569 cancer:0.919855798038651 men:0.87618073453599 years:2.04646830498498 found:1.76715365842585 health:1.34789522818535 larry:4.9452074887738 selenium:1.07400647786591 toenails:0.396607654274103 melanoma:4.53974238066564 men:4.08506565095307 follow:0.153557735843091 population:0.514390689930487 professionals:3.44113009199753 advanced:3.84659520010569 randomized:1.17244655067916 measured:3.84659520010569 skin:3.69244452027843 source:2.54731221597543 study:0.296020417368935 men:8.0578335137993 trial:1.54401010711165 toenails:0.970126149671934
263310 302470 developing:3.55891312765391 calculate:0.550758334101362 prostate:1.54401010711165 trial:1.14971829960161 cancer:0.634408363388287 paper:2.11199414471758 risk:0.87618073453599 risk:0.748005541111992 found:1.76715365842585 highest:3.15344801954575 levels:2.14801295573182 estimate:0.984394319176222 60:1.47947158597407 men:3.44113009199753 measure:0.396607654274103 men:2.72337710063538 odds:0.984394319176222 read:1.7263316639056 advanced:3.84659520010569 talk:0.520360856916991 results:1.17244655067916 ratios:0.654748047625409 chance:1.52748080516043 relative:4.68503560665884 line:0.634408363388287 risk:1.84342244546241 selenium:3.84659520010569 detail:0.42341891172476 toenails:4.02891675689965 randomized:1.54401010711165
302470 337400 question:2.14184710786727 case:3.55891312765391 authors:3.24045939653538 address:0.550758334101362 prostate:1.54401010711165 case:0.650297380583916 cohort:2.32203570971108 bit:2.4603008389858 conducted:2.54731221597543 control:0.919855798038651 critiquing:3.44113009199753 sampling:1.14971829960161 researchers:1.83169217956343 cohort:2.69391569016731 nested:2.93030446823154 complex:2.80514132527753 advanced:3.84659520010569 question:1.56108257075097 design:1.94947521521981 principles:0.614474148487469 set:0.668541369757745 risk:0.37566448042886 study:0.888061252106805 thinking:1.83169217956343
337400 377090 advanced:3.55891312765391 cancer:3.0880202142233 case:0.325148690291958 control:1.8397115960773 definition:1.68711095075232 diagnosed:5.00418826734486 discuss:1.9747930232041 1993:2.86576594709396 control:0.153557735843091 participant:7.69913041051776 population:0.514390689930487 risk:1.47947158597407 prostate:7.69319040021138 question:1.04072171383398 risk:1.84342244546241 sampled:1.33708273951549 set:0.75132896085772 source:2.54731221597543
377090 408430 case:0.325148690291958 simply:2.59383223161032 control:0.919855798038651 diagnosed:1.66806275578162 exclude:2.86576594709396 selenium:2.58909849496012 relates:0.396607654274103 exposure:4.9452074887738 person:0.582108863985438 potential:1.47947158597407 question:1.56108257075097 question:1.28164584264415 measurement:3.84659520010569 oftentimes:2.59383223161032 exposure:0.296020417368935 study:0.209009040379305
408430 439870 years:1.70652903660942 case:0.325148690291958 complicated:2.59383223161032 continuous:1.49521994294221 divided:0.725699783597694 equal:0.462204936759917 exposure:2.58909849496012 groups:0.249282939517245 happened:0.60791674794131 levels:1.07400647786591 measure:0.793215308548206 oftentimes:4.9452074887738 question:0.520360856916991 quintiles:4.53974238066564 reflect:3.07340531187221 reflect:2.99043988588442 selenium:7.69319040021138 study:0.296020417368935 window:2.38025813131226 20:0.485063074835967 yesno:4.25206030821386
439870 476700 bias:5.9243790696123 biases:2.64262239577975 concepts:1.92478260262944 concerned:2.08300660784433 core:4.25206030821386 epidemiology:1.43366204994278 estimate:0.748005541111992 exposure:2.58909849496012 finally:1.21951406153715 findings:0.778542264972074 gonna:3.55891312765391 great:2.34251780332942 influence:5.84842564565943 interpretation:1.52748080516043 limitations:1.66806275578162 measurement:0.793215308548206 potential:2.95894317194814 relative:2.34251780332942 relate:1.28164584264415 risk:0.614474148487469 study:0.296020417368935
476700 514980 secondary:1.14971829960161 risk:1.54401010711165 clark:3.84659520010569 compare:1.26881672677657 contrast:3.3357695763397 randomized:2.41947884446554 final:1.21951406153715 1996:1.76715365842585 larry:4.9452074887738 selenium:1.47947158597407 analysis:2.72337710063538 men:2.5028604534046 lower:3.84659520010569 published:2.38025813131226 question:1.04072171383398 randomized:3.51733965203748 relates:1.28164584264415 60:0.614474148487469 found:4.02891675689965 randomized:3.84659520010569 study:1.48010208684467 subsequent:3.07340531187221 undertaken:9.07948476133128
514980 552200 advanced:3.55891312765391 agent:2.93030446823154 ago:1.70652903660942 association:1.11656609228471 based:1.00362568110411 biomarkers:3.55891312765391 blood:1.40424816473649 cancer:6.1760404284466 chemo:4.9452074887738 conducted:2.54731221597543 data:0.231182897873627 epidemiological:2.41947884446554 found:1.76715365842585 institute:3.3357695763397 inverse:2.99929733971849 levels:1.07400647786591 national:2.4603008389858 potential:1.47947158597407 preventive:2.59383223161032 prostate:11.5397856003171 risk:1.22894829697494 select:2.89739985461464 selenium:15.3863808004228 specifically:1.29454924748006 study:0.296020417368935 thinking:1.83169217956343 toenails:4.02891675689965 trail:4.9452074887738 trial:1.54401010711165 undertaken:4.53974238066564 undertook:4.53974238066564 years:0.485063074835967
552200 583700 placebo:2.1689555554664 randomized:0.281768394661733 cancer:3.0880202142233 factorial:1.14971829960161 time:2.64262239577975 called:3.44113009199753 published:1.02323415249249 states:2.64262239577975 35000:1.36168855031769 vitamin:2.5028604534046 prevention:2.59383223161032 primary:2.38025813131226 prostate:3.84659520010569 study:2.38025813131226 diagnosis:1.17244655067916 design:1.87715455364018 recruited:3.07340531187221 received:7.69319040021138 united:1.41884696415764 average:0.59204083473787 cancer:0.0700101655726489 men:1.70652903660942 selenium:5.99859467943698 study:0.485063074835967
583700 623410 question:2.02743675668952 association:1.11656609228471 cancer:3.0880202142233 clark:3.84659520010569 question:0.634408363388287 contrast:3.3357695763397 randomized:0.919855798038651 advantages:2.99929733971849 protective:0.96552583487184 epidemiological:4.83895768893108 found:1.87715455364018 found:3.5343073168517 cancer:2.64262239577975 larry:4.9452074887738 supplementation:2.59383223161032 prostate:7.69319040021138 evidence:3.07340531187221 guess:1.04072171383398 randomization:2.34489310135832 relative:2.34251780332942 results:0.634408363388287 risk:1.22894829697494 selenium:7.69319040021138 studies:0.888061252106805 selenium:3.69244452027843 control:1.54401010711165
623410 654100 answers:0.538488241509547 bias:1.9747930232041 comments:2.86576594709396 comparison:1.9747930232041 concerned:2.08300660784433 confounding:1.36168855031769 controlled:0.919855798038651 critique:6.88226018399506 epidemiological:2.41947884446554 explanations:2.38025813131226 exposure:1.29454924748006 final:1.21951406153715 forward:2.30615015915854 interpretation:1.52748080516043 letting:3.24045939653538 logging:2.34251780332942 outcomes:0.654748047625409 part:1.0844777777332 plausible:3.44113009199753 post:2.86576594709396 providing:2.05483573087764 question:1.04072171383398 randomized:1.17244655067916 study:0.888061252106805 thoughts:1.92478260262944
